Time to include sarcopenia into the oncological routine
- PMID: 37413844
- DOI: 10.1016/j.ejca.2023.112939
Time to include sarcopenia into the oncological routine
Conflict of interest statement
Declaration of Competing Interest AS, AW: None. RG: Research support from Novartis, SUN Pharma, Amgen, Sanofi, Merck-Serono, Kyowa-Kirin, Almirall-Hermal. Honoraria for lectures and advice: Roche Pharma, Bristol-MyersSquibb, Novartis, MSD, Almirall-Hermal, Amgen, Merck-Serono, SUN Pharma, Pierre-Fabre, Sanofi, 4SC, Immunocore, Delcath, Regeneron. JB: Research support/speaker honoraria from Siemens Healthineers and Philips Healthcare.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
